dalteparin has been researched along with epoetin alfa in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chester, K; McMahon, LP; Walker, RG | 1 |
| Anaissie, EJ; Bailey, C; Barlogie, B; Coleman, EA; Coon, SK; Goodwin, JA; Kennedy, RL; Lockhart, KD; Stewart, CB | 1 |
2 other study(ies) available for dalteparin and epoetin alfa
| Article | Year |
|---|---|
Effects of different dialysis membranes on serum concentrations of epoetin alfa, darbepoetin alfa, enoxaparin, and iron sucrose during dialysis.
Topics: Adult; Aged; Darbepoetin alfa; Enoxaparin; Epoetin Alfa; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematologic Agents; Humans; Male; Middle Aged; Prospective Studies; Recombinant Proteins; Renal Dialysis | 2004 |
Prophylactic recombinant erythropoietin therapy and thalidomide are predictors of venous thromboembolism in patients with multiple myeloma: limited effectiveness of thromboprophylaxis.
Topics: Adult; Aged; Anticoagulants; Enoxaparin; Epoetin Alfa; Erythropoietin; Female; Humans; Male; Middle Aged; Multiple Myeloma; Recombinant Proteins; Risk Factors; Thalidomide; Venous Thromboembolism | 2012 |